Fiche publication
Date publication
mars 2016
Journal
European journal of cancer (Oxford, England : 1990)
Auteurs
Membres identifiés du Cancéropôle Est :
Mme POZET Astrid
Tous les auteurs :
Lledo G, Huguet F, Chibaudel B, Di Fiore F, Mineur L, Galais MP, Artru P, Blondin V, Dupuis O, Abdiche MS, Jovenin N, Pozet A, Bonnetain F, Attia M, Dahan L, de Gramont A
Lien Pubmed
Résumé
To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer.
Mots clés
Antineoplastic Combined Chemotherapy Protocols, adverse effects, Cetuximab, administration & dosage, Chemoradiotherapy, adverse effects, Disease-Free Survival, Esophageal Neoplasms, mortality, Esophagogastric Junction, drug effects, Fluorouracil, administration & dosage, France, Humans, Kaplan-Meier Estimate, Leucovorin, administration & dosage, Neoplasm Staging, Organoplatinum Compounds, administration & dosage, Proportional Hazards Models, Prospective Studies, Radiotherapy Dosage, Time Factors, Treatment Outcome
Référence
Eur. J. Cancer. 2016 Mar;56:115-121
